ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 134 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $175,956 | +643.5% | 18,920 | +692.3% | 0.00% | +200.0% |
| Q1 2024 | $23,665 | +65.8% | 2,388 | -46.0% | 0.00% | – |
| Q4 2023 | $14,273 | -30.4% | 4,419 | +14.4% | 0.00% | -100.0% |
| Q3 2023 | $20,513 | -82.0% | 3,863 | -67.8% | 0.00% | -75.0% |
| Q2 2023 | $114,274 | +393948.3% | 11,991 | +357.0% | 0.00% | +300.0% |
| Q1 2023 | $29 | -77.9% | 2,624 | -70.4% | 0.00% | -80.0% |
| Q4 2022 | $131 | -99.8% | 8,865 | +213.3% | 0.01% | +400.0% |
| Q3 2022 | $54,000 | -78.7% | 2,830 | -76.2% | 0.00% | -83.3% |
| Q2 2022 | $253,000 | +1481.2% | 11,877 | +1282.7% | 0.01% | – |
| Q1 2022 | $16,000 | -57.9% | 859 | -52.3% | 0.00% | -100.0% |
| Q4 2021 | $38,000 | +65.2% | 1,799 | +80.6% | 0.00% | 0.0% |
| Q3 2021 | $23,000 | -70.5% | 996 | -65.1% | 0.00% | -50.0% |
| Q2 2021 | $78,000 | +116.7% | 2,856 | +132.4% | 0.00% | +100.0% |
| Q1 2021 | $36,000 | +227.3% | 1,229 | +223.4% | 0.00% | – |
| Q4 2020 | $11,000 | -96.7% | 380 | -96.6% | 0.00% | -100.0% |
| Q3 2020 | $332,000 | +591.7% | 11,340 | +615.9% | 0.00% | +100.0% |
| Q2 2020 | $48,000 | +26.3% | 1,584 | +25.5% | 0.00% | 0.0% |
| Q1 2020 | $38,000 | – | 1,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $305,003,000 | 24.46% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $115,121,000 | 6.52% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $16,462,000 | 5.28% |
| SECTORAL ASSET MANAGEMENT INC | 878,948 | $25,428,000 | 1.93% |
| Omega Fund Management, LLC | 623,836 | $18,048,000 | 1.71% |
| Orbimed Advisors | 6,073,850 | $175,716,000 | 1.64% |
| Altium Capital Management LP | 113,962 | $3,297,000 | 0.92% |
| Vivo Capital, LLC | 744,370 | $21,535,000 | 0.76% |
| Polar Capital Holdings Plc | 1,557,543 | $45,060,000 | 0.28% |
| Birchview Capital, LP | 9,000 | $260,000 | 0.15% |